Cargando…
Effective Anti–SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders
BACKGROUND: Mast cells are key players in innate immunity and the T(H)2 adaptive immune response. The latter counterbalances the T(H)1 response, which is critical for antiviral immunity. Clonal mast cell activation disorders (cMCADs, such as mastocytosis and clonal mast cell activation syndrome) are...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780123/ https://www.ncbi.nlm.nih.gov/pubmed/35074600 http://dx.doi.org/10.1016/j.jaip.2021.12.038 |